Description
An inhibitor of FGFR4 (IC50 = 1.3 nM); selective for FGFR4 over FGFR1 and a panel of 36 kinases (IC50s = >10 µM for all); inhibits proliferation of Hep3B and Huh7 hepatic cancer cells with IC50 values of 1.1 and 2.5 nM, respectively; reduces tumor growth by 62.7 and 70.8% in a Huh7 mouse xenograft model at 30 and 100 mg/kg per day, respectively
Formal name: N-[5-cyano-4-[(2-methoxyethyl)amino]-2-pyridinyl]-7-formyl-3,4-dihydro-6-[(3-oxo-4-morpholinyl)methyl]-1,8-naphthyridine-1(2H)-carboxamide
Synonyms:
Molecular weight: 493.5
CAS: 1708971-72-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|FGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling